The Winship Cancer Institute's Cancer Cell Biology (CCB) Program studies the changes in biological function of human cells as a result of cell transformation. The CCB Program consists of 36 core members from 15 departments across Emory University, including the Schools of Medicine and Public Health and Emory College. The CCB program has two main themes: 1) Cell Survival and Death Mechanisms, and 2) Cell Adhesion, Communication and Metastasis. The CCB Program serves as Winship's scientific switchboard, a platform for discovery of novel signaling pathways, their biological validation, and an interchange of concepts among the CGE, DDT, and CPC Programs. Strategic reorganization toward increased cohesion and clarity has helped make the current project period a highly productive one for the CCB Program. CCB labs identified and targeted key molecular pathways involved in a variety of disease site-specific cancers. Its members published 300 cancer-related publications, many of which appeared in high-impact journals. The program furthered important initiatives, including the establishment of the In Silico Brain Tumor Research Center. Using start-up funding from internal pilot grants, CCB members expanded pilot science into nationally funded projects. CCB Program members currently have $23,452,748 in research grant funding (annual direct costs), of which $19,909,676 is peer-reviewed and $9,489,373 is NCI funded. As Winship's platform for scientific exchange, the CCB Program's productivity has been a win for all of the research programs and has spurred important inter-programmatic collaborations. The program has published 300 cancer-related publications in the current project period, most of which appeared in influential journals. Among these, approximately or neariy 15% represent intra-programmatic and 38% represent inter-programmatic interactions. CCB members and collaborators have contributed to the field of cancer research in a number of significant ways, and the program is poised for continued success going into the next project period.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Center Core Grants (P30)
Project #
Application #
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Emory University
United States
Zip Code
Hou, Yue; Konen, Jessica; Brat, Daniel J et al. (2018) TASI: A software tool for spatial-temporal quantification of tumor spheroid dynamics. Sci Rep 8:7248
Greenwell, I Brian; Staton, Ashley D; Lee, Michael J et al. (2018) Complex karyotype in patients with mantle cell lymphoma predicts inferior survival and poor response to intensive induction therapy. Cancer 124:2306-2315
Patel, Mihir R; Hudgins, Patricia A; Beitler, Jonathan J et al. (2018) Radiographic Imaging Does Not Reliably Predict Macroscopic Extranodal Extension in Human Papilloma Virus-Associated Oropharyngeal Cancer. ORL J Otorhinolaryngol Relat Spec 80:85-95
Sadigh, Gelareh; Duszak Jr, Richard; Ward, Kevin C et al. (2018) Downstream Breast Imaging Following Screening Mammography in Medicare Patients with Advanced Cancer: A Population-Based Study. J Gen Intern Med 33:284-290
Goldstein, Jordan S; Nastoupil, Loretta J; Han, Xuesong et al. (2018) Disparities in survival by insurance status in follicular lymphoma. Blood 132:1159-1166
Richardson, Alessandra M; Havel, Lauren S; Koyen, Allyson E et al. (2018) Vimentin Is Required for Lung Adenocarcinoma Metastasis via Heterotypic Tumor Cell-Cancer-Associated Fibroblast Interactions during Collective Invasion. Clin Cancer Res 24:420-432
Jin, Lingtao; Chun, Jaemoo; Pan, Chaoyun et al. (2018) MAST1 Drives Cisplatin Resistance in Human Cancers by Rewiring cRaf-Independent MEK Activation. Cancer Cell 34:315-330.e7
Guidot, Daniel M; Switchenko, Jeffrey M; Nastoupil, Loretta J et al. (2018) Surveillance imaging in mantle cell lymphoma in first remission lacks clinical utility. Leuk Lymphoma 59:888-895
Chowdhary, Mudit; Okwan-Duodu, Derick; Switchenko, Jeffrey M et al. (2018) Angiotensin receptor blockade: a novel approach for symptomatic radiation necrosis after stereotactic radiosurgery. J Neurooncol 136:289-298
Chen, Zhengjia; Zheng, Youyun; Wang, Zhibo et al. (2018) Interactive calculator for operating characteristics of phase I cancer clinical trials using standard 3+3 designs. Contemp Clin Trials Commun 12:145-153

Showing the most recent 10 out of 331 publications